Begin typing your search above and press return to search.

Oxford vaccine trial to resume

By The Assam Tribune

LONDON, Sept 12 - Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the UK. The university said in large trials �it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.�

Globally some 18,000 people have received the vaccine as part of the trial.

Oxford would not disclose information about the patient�s illness for reasons of confidentiality but said it is �committed to the safety of our participants and the highest standards of conduct in our studies.� � AP

Next Story